Related Experiment Video
Updated: Jul 20, 2026

06:56
Influenza Virus Propagation in Embryonated Chicken Eggs
Published on: March 19, 2015
Current issues with influenza vaccination in egg allergy
1Department of Allergy, Kaiser Permanente Medical Center San Diego, California 92111, USA.
The Journal of Allergy and Clinical Immunology
|December 5, 2002
Summary
Influenza vaccination is crucial for high-risk groups, but egg allergies can be a barrier. This study presents a safe protocol for vaccinating asthmatic patients with egg allergies, ensuring better influenza prevention.
Area of Science:
- Immunology
- Public Health
- Allergy & Immunology
Background:
- Influenza poses significant annual risks, particularly to the elderly and high-risk individuals like asthmatics.
- Low immunization rates highlight challenges in influenza prevention strategies.
- Egg allergy is a common concern that can prevent eligible individuals from receiving influenza vaccination.
Purpose of the Study:
- To address the challenge of influenza vaccination in patients with egg allergy.
- To provide a practical protocol for safe influenza immunization in high-risk individuals with egg allergies.
- To improve influenza vaccine uptake in a vulnerable patient population.
Main Methods:
- Review of evidence supporting influenza vaccine safety in egg-allergic individuals.
- Development of a practical protocol for incremental influenza vaccine dosing.
- Guidance for clinicians on managing influenza vaccination in this specific risk group.
Main Results:
- Evidence supports the safe administration of influenza vaccines to individuals with egg allergies under specific conditions.
- A protocol involving incremental dosing can mitigate risks associated with influenza vaccination in egg-allergic patients.
- Physician supervision and adherence to protocols are key to successful vaccination.
Conclusions:
- Influenza vaccination is feasible and safe for asthmatic patients with egg allergies when specific protocols are followed.
- The presented incremental dosing protocol offers a practical approach to overcome vaccination barriers in this high-risk group.
- Improved vaccination strategies are essential to enhance influenza protection in vulnerable populations.
Related Concept Videos
Cross-reactivity
Overview
Allergic Reactions
Overview
Vaccinations
Overview
Allergic Drug Reactions
Allergic reactions related to drugs are hypersensitivity responses driven by the immune system and bear no connection to the drug's therapeutic action. While drugs in isolation do not trigger an immune response, they can interact with endogenous proteins to form antigens. These antigens stimulate lymphocytes to produce antibodies. IgE-type antibodies attach themselves to mast cells. Upon subsequent exposure to the same stimulus, the antigen-antibody interaction is initiated, unleashing numerous...
Allergic Reactions: Anaphylaxis
Anaphylaxis is a severe, life-threatening hypersensitivity reaction mediated by Immunoglobulin E (IgE) antibodies. When IgE binds to allergens, it triggers the release of mediators– histamine, leukotrienes, and prostaglandins from mast cells and basophils. These mediators cause vasodilation, edema, and inflammation, leading to various symptoms.The primary allergens causing anaphylaxis include food items (e.g., peanuts, shellfish), drugs (e.g., penicillin, asparaginase, corticotropin, heparin),...
Influenza
Influenza is an acute, highly communicable viral disease that affects the respiratory tract and is responsible for seasonal epidemics worldwide. Influenza A is the most prevalent type associated with widespread outbreaks and is subtyped based on two surface glycoproteins: hemagglutinin (H) and neuraminidase (N), as in H1N1. These glycoproteins are essential for viral infectivity, transmission, and immune recognition. Transmission occurs primarily through respiratory droplets and contaminated...

